Medical Care Technologies Inc. (OTC PINK:MDCE) Advances Skin Cancer Prevention with AI Mole Tracking System
Medical Care Technologies (OTC PINK:MDCE) has announced the development of an AI-driven Mole Tracking System for early skin cancer detection. The innovative system utilizes full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection to create comprehensive dermatological profiles.
The technology aims to reduce dependence on invasive biopsies and expensive clinic visits by providing a consumer-facing, mobile-accessible solution. The system will be integrated into MDCE's beta app, scheduled for launch in 2026. The company is targeting the global dermatology diagnostics market, which currently exceeds $15 billion annually.
Medical Care Technologies (OTC PINK:MDCE) ha annunciato lo sviluppo di un Sistema di Tracciamento dei Nei basato su IA per la diagnosi precoce del cancro della pelle. Il sistema innovativo sfrutta l'indicizzazione delle lesioni su tutto il corpo, algoritmi di mappatura corporea 3D e il rilevamento temporale dei cambiamenti cutanei per creare profili dermatologici completi.
La tecnologia punta a ridurre la dipendenza da biopsie invasive e da costose visite cliniche offrendo una soluzione rivolta ai consumatori e accessibile da dispositivi mobili. Il sistema verrà integrato nell'app beta di MDCE, il cui lancio è previsto per il 2026. L'azienda si rivolge al mercato globale della diagnostica dermatologica, che attualmente supera i $15 miliardi all'anno.
Medical Care Technologies (OTC PINK:MDCE) ha anunciado el desarrollo de un Sistema de Seguimiento de Lunares impulsado por IA para la detección temprana del cáncer de piel. El sistema innovador utiliza la indexación de lesiones en todo el cuerpo, algoritmos de mapeo corporal 3D y la detección temporal de cambios en la piel para crear perfiles dermatológicos completos.
La tecnología busca reducir la dependencia de biopsias invasivas y de costosas visitas clínicas ofreciendo una solución orientada al consumidor y accesible desde dispositivos móviles. El sistema se integrará en la app beta de MDCE, cuyo lanzamiento está previsto para 2026. La compañía apunta al mercado global de diagnóstico dermatológico, que actualmente supera los $15.000 millones anuales.
Medical Care Technologies (OTC PINK:MDCE)는 조기 피부암 발견을 위한 AI 기반 점(모반) 추적 시스템 개발을 발표했습니다. 이 혁신적인 시스템은 전신 병변 인덱싱, 3D 신체 매핑 알고리즘 및 시간에 따른 피부 변화 감지를 활용해 포괄적인 피부과 프로파일을 생성합니다.
이 기술은 소비자용 모바일 접근 가능한 솔루션을 제공함으로써 침습적 생검과 고가의 진료 방문에 대한 의존도를 줄이는 것을 목표로 합니다. 해당 시스템은 2026년에 출시 예정인 MDCE의 베타 앱에 통합될 예정입니다. 회사는 현재 연간 $150억을 초과하는 글로벌 피부과 진단 시장을 목표로 하고 있습니다.
Medical Care Technologies (OTC PINK:MDCE) a annoncé le développement d'un Système de Suivi des Grains de Beauté piloté par IA pour la détection précoce du cancer de la peau. Le système innovant utilise l'indexation des lésions sur l'ensemble du corps, des algorithmes de cartographie corporelle 3D et la détection des changements cutanés dans le temps pour créer des profils dermatologiques complets.
La technologie vise à réduire la dépendance aux biopsies invasives et aux visites cliniques coûteuses en proposant une solution destinée aux consommateurs et accessible depuis un mobile. Le système sera intégré à l'application bêta de MDCE, dont le lancement est prévu en 2026. La société cible le marché mondial du diagnostic dermatologique, qui dépasse actuellement les 15 milliards de dollars par an.
Medical Care Technologies (OTC PINK:MDCE) hat die Entwicklung eines KI-basierten Muttermal-Tracking-Systems zur frühzeitigen Erkennung von Hautkrebs angekündigt. Das innovative System nutzt die Indexierung von Läsionen am ganzen Körper, 3D-Körperkartierungsalgorithmen und die zeitliche Erkennung von Hautveränderungen, um umfassende dermatologische Profile zu erstellen.
Die Technologie zielt darauf ab, die Abhängigkeit von invasiven Biopsien und teuren Klinikbesuchen zu verringern, indem sie eine verbraucherorientierte, mobil zugängliche Lösung bietet. Das System wird in die Beta-App von MDCE integriert, deren Start für 2026 geplant ist. Das Unternehmen richtet sich an den globalen Markt für Dermatologie-Diagnostik, der derzeit mehr als $15 Milliarden jährlich umfasst.
- Targeting $15 billion global dermatology diagnostics market with growth potential
- Innovative AI technology reduces need for invasive biopsies and costly clinic visits
- Mobile-accessible solution expands market reach to consumers
- Beta app launch not until 2026, indicating long time to market
- Faces regulatory approval hurdles and development timeline uncertainties
- Operating in highly competitive medical technology market
MESA, ARIZONA / ACCESS Newswire / September 4, 2025 / Medical Care Technologies Inc. (OTC PINK: MDCE) is proud to announce the development of its AI-driven Mole Tracking System, a breakthrough dermatological monitoring tool for early skin cancer detection.
The system uses full-body lesion indexing, 3D body-mapping algorithms, and temporal skin-change detection to create longitudinal dermatological profiles for patients. This approach enables early identification of melanoma and other high-risk conditions, reducing reliance on invasive biopsies and costly clinic visits.
The global dermatology diagnostics market exceeds
"Skin cancer remains one of the most preventable yet deadly cancers when detected late," said CEO Marshall Perkins III. "Our technology empowers individuals and providers with AI-driven, real-time insights that can save lives."
The AI Mole Tracking platform is scheduled for inclusion in MDCE's beta app launch in 2026.
For more information visit: https://medicalcaretechnologies.com
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of federal securities laws. Actual results may differ materially due to risks and uncertainties, including market conditions, regulatory approvals, and product development timelines. Medical Care Technologies Inc. undertakes no obligation to update these statements except as required by law.
Contact:
Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com
SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)
View the original press release on ACCESS Newswire
FAQ
What is MDCE's new AI Mole Tracking System?
When will MDCE launch its AI mole tracking app?
How big is the market opportunity for MDCE's skin cancer detection technology?
What advantages does MDCE's AI mole tracking system offer?
Who is the CEO of Medical Care Technologies (MDCE)?
